Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 12 results.
User Information
Export Records
  1. 1.   Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications
  2. Kwon, M. J.; Kim, S. S.; Choi, Y. L.; Jung, H. S.; Balch, C.; Kim, S. H.; Song, Y. S.; Marquez, V. E.; Nephew, K. P.; Shin, Y. K.
  3. Carcinogenesis. 2010, Jun; 31(6): 974-983.
  1. 2.   Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice
  2. Suzuki, T.; Minehata, K.; Akagi, K.; Jenkins, N. A.; Copeland, N. G.
  3. Embo Journal. 2006, Jul; 25(14): 3422-3431.
  1. 3.   Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells
  2. de la Pena, L.; Burgan, W. E.; Carter, D. J.; Hollingshead, M. G.; Satyamitra, M.; Camphausen, K.; Tofilon, P. J.
  3. Molecular Cancer Therapeutics. 2006, Jun; 5(6): 1504-1510.
  1. 4.   An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model
  2. Reilly, K. M.; Broman, K. W.; Bronson, R. T.; Tsang, S.; Loisel, D. A.; Christy, E. S.; Sun, Z. H.; Diehl, J.; Munroe, D. J.; Tuskan, R. G.
  3. Cancer Research. 2006, JAN 1; 66(1): 62-68.
  1. 5.   Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation
  2. Hodge, D. R.; Peng, B.; Cherry, J. C.; Hurt, E. M.; Fox, S. D.; Kelley, J. A.; Munroe, D. J.; Farrar, W. L.
  3. Cancer Research. 2005, JUN 1; 65(11): 4673-4682.
  1. 6.   Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by zebularine on L1210 leukemia
  2. Lemaire, M.; Momparler, L. F.; Bernstein, M. L.; Marquez, V. E.; Momparler, R. L.
  3. Anti-Cancer Drugs. 2005, MAR; 16(3): 301-308.
  1. 7.   The importance of genome architecture in cancer susceptibility - Location, location, location
  2. Reilly, K. M.
  3. Cell Cycle. 2004, NOV; 3(11): 1378-1382.
  1. 8.   Preferential response of cancer cells to zebularine
  2. Cheng, J. C.; Yoo, C. B.; Weisenberger, D. J.; Chuang, J.; Wozniak, C.; Liang, G. N.; Marquez, V. E.; Greer, S.; Orntoft, T. F.; Thykjaer, T.; Jones, P. A.
  3. Cancer Cell. 2004, AUG; 6(2): 151-158.
  1. 9.   RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies
  2. Kashuba, V. I.; Li, J. F.; Wang, F. L.; Senchenko, V. N.; Protopopov, A.; Malyukova, A.; Kutsenko, A. S.; Kadyrova, E.; Zabarovska, V. I.; Muravenko, O. V.; Zelenin, A. V.; Kisselev, L. L.; Kuzmin, I.; Minna, J. D.; Winberg, G.; Ernberg, I.; Braga, E.; Lerman, M. I.; Klein, G.; Zabarovsky, E. R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(14): 4906-4911.
  1. 10.   Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas
  2. Senchenko, V.; Liu, J.; Braga, E.; Mazurenko, N.; Loginov, W.; Seryogin, Y.; Bazov, I.; Protopopov, A.; Kisseljov, F. L.; Kashuba, V.; Lerman, M. I.; Klein, G.; Zabarovsky, E. R.
  3. Oncogene. 2003 22(19): 2984-2992.
  1. 11.   Analysis of aberrant methylation of the VHL gene by transgenes, monochromosome transfer, and cell fusion
  2. Kuzmin, I.; Geil, L.; Ge, H. Y.; Bengtsson, U.; Duh, F. M.; Stanbridge, E. J.; Lerman, M. I.
  3. Oncogene. 1999 18(41): 5672-5679.
  1. 12.   Mechanism-based cancer prevention approaches: Targets, examples, and the use of transgenic mice
  2. Hursting, S. D.; Slaga, T. J.; Fischer, S. M.; DiGiovanni, J.; Phang, J. M.
  3. Journal of the National Cancer Institute. 1999 91(3): 215-225.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel